Detalhe da pesquisa
1.
Virtual screening and biological evaluation of PPARγ antagonists as potential anti-prostate cancer agents.
Bioorg Med Chem
; 46: 116368, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433102
2.
Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.
Prostate
; 80(2): 162-172, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769890
3.
The androgen receptor malignancy shift in prostate cancer.
Prostate
; 78(7): 521-531, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473182
4.
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).
Cancer
; 124(6): 1216-1224, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266182
5.
Low Testosterone Alters the Activity of Mouse Prostate Stem Cells.
Prostate
; 77(5): 530-541, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27976414
6.
High-Throughput Screen for Inhibitors of Androgen Receptor-RUNX2 Transcriptional Regulation in Prostate Cancer.
J Pharmacol Exp Ther
; 359(2): 256-261, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27554677
7.
Pazopanib as third line therapy for metastatic renal cell carcinoma: clinical efficacy and temporal analysis of cytokine profile.
J Urol
; 193(4): 1114-21, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25286010
8.
Non-competitive androgen receptor inhibition in vitro and in vivo.
Proc Natl Acad Sci U S A
; 106(17): 7233-8, 2009 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19363158
9.
Tissue-selective regulation of androgen-responsive genes.
Endocr Res
; 37(4): 203-15, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22591338
10.
Circulating tumor DNA analysis of metastatic renal cell carcinoma.
Mol Clin Oncol
; 14(1): 16, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33312563
11.
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.
Prostate Cancer Prostatic Dis
; 24(2): 448-456, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33009489
12.
Circulating tumor cells in prostate cancer: Does (nuclear) size matter?
Cancer
; 121(18): 3190-2, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25980931
13.
Different roles of peroxisome proliferator-activated receptor gamma isoforms in prostate cancer.
Am J Clin Exp Urol
; 7(3): 98-109, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31317050
14.
Factors that influence the androgen receptor cistrome in benign and malignant prostate cells.
Mol Oncol
; 13(12): 2616-2632, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31520575
15.
Androgen Receptor and PI3K Pathway Activity in Ovarian Cancer.
J Cancer Res Ther Oncol
; 7(1)2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34926721
16.
Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium.
ACS Omega
; 4(2): 2472-2481, 2019 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30873507
17.
The role of peroxisome proliferator-activated receptor gamma in prostate cancer.
Asian J Androl
; 20(3): 238-243, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28597850
18.
Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide.
Urol Oncol
; 36(4): 162.e1-162.e6, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29289429
19.
Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.
Endocrinology
; 148(2): 538-47, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17095596
20.
Identification of neuron selective androgen receptor inhibitors.
World J Biol Chem
; 8(2): 138-150, 2017 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28588757